CAC
VHAQ.RT

Cowen and Company’s Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock VHAQ.RT Stock Holding History

Cowen and Company’s Portfolio VHAQ.RT Stock Details VHAQ.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-526,475
Closed -$31.6K – 785
2023
Q4 		$31.6K Buy
526,475
+6,200
+1% +$350 ﹤0.01% 309
2023
Q3 		$31.6K Hold
520,275
– – ﹤0.01% 331
2023
Q2 		$29.8K Buy
520,275
+2,975
+0.6% +$179 ﹤0.01% 297
2023
Q1 		$25.9K Buy
517,300
+217,090
+72% +$19.5K ﹤0.01% 280
2022
Q4 		$39.1K Buy
300,210
+62,177
+26% +$7.78K ﹤0.01% 283
2022
Q3 		$29K Buy
238,033
+2,700
+1% +$308 ﹤0.01% 308
2022
Q2 		$19K Buy
235,333
+17,773
+8% +$2.37K ﹤0.01% 401
2022
Q1 		$26K Sell
217,560
-64,956
-23% -$10.4K ﹤0.01% 399
2021
Q4 		$52K Buy
+282,516
New +$58.4K ﹤0.01% 435
2021
Q2 		– Sell
-25,000
Closed -$5K – 734
2021
Q1 		$5K Buy
+25,000
New +$5.83K ﹤0.01% 512

Other funds holding VHAQ.RT

SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return

Cowen and Company's VHAQ.RT Position: Q1 2024 in Review

Cowen and Company sold out of Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) in Q1 2024, closing a stake of 526,475 shares — an estimated $31.6K sold.

Cowen and Company first reported a position in VHAQ.RT in Q1 2021 and held it in 10 quarters. The position peaked at $52K in Q4 2021. 5 funds tracked by Wall St. Rank hold VHAQ.RT as of Q1 2024.

  • Cowen and Company reported no remaining Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position as of Q1 2024 after selling out during the quarter.
  • Cowen and Company sold 526,475 Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock shares in Q1 2024, an estimated $31.6K.
  • Cowen and Company first reported a position in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock in Q1 2021 and held it in 10 quarters.
  • Cowen and Company's Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position peaked at $52K in Q4 2021.
  • 5 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock as of Q1 2024.

Based on Cowen and Company's 13F filing for Q1 2024, filed 3 May 2024.